[HTML][HTML] Nanosensors and their applications in early diagnosis of cancer

M Khazaei, MS Hosseini, AM Haghighi… - Sensing and Bio-Sensing …, 2023 - Elsevier
According to WHO and other key statistics, cancer is a leading cause of death worldwide,
accounting for nearly 10 million deaths in 2020. By identifying cancer early, it is more likely …

Nanotreatment and nanodiagnosis of prostate cancer: recent updates

M Barani, F Sabir, A Rahdar, R Arshad, GZ Kyzas - Nanomaterials, 2020 - mdpi.com
The fabrication and development of nanomaterials for the treatment of prostate cancer have
gained significant appraisal in recent years. Advancements in synthesis of organic and …

Giant magnetoresistance based biosensors for cancer screening and detection

S Mostufa, B Rezaei, P Yari, K Xu… - ACS Applied Bio …, 2023 - ACS Publications
Early-stage screening of cancer is critical in preventing its development and therefore can
improve the prognosis of the disease. One accurate and effective method of cancer …

Hidden in plants—A review of the anticancer potential of the Solanaceae family in in vitro and in vivo studies

T Kowalczyk, A Merecz-Sadowska, P Rijo, M Mori… - Cancers, 2022 - mdpi.com
Simple Summary The Solanaceae family is one of the most important arable and economic
families in the world. In addition, it includes a wide range of valuable active secondary …

Retinal degeneration: a window to understand the origin and progression of Parkinson's disease?

Y Zhang, X Zhang, Y Yue, T Tian - Frontiers in Neuroscience, 2022 - frontiersin.org
Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, manifests
with motor and non-motor symptoms associated with two main pathological hallmarks …

Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells

KM Launonen, V Paakinaho, G Sigismondo, M Malinen… - Oncogene, 2021 - nature.com
Abstract Treatment of prostate cancer confronts resistance to androgen receptor (AR)-
targeted therapies. AR-associated coregulators and chromatin proteins hold a great …

The paradox of cancer genes in non-malignant conditions: implications for precision medicine

JJ Adashek, S Kato, SM Lippman, R Kurzrock - Genome medicine, 2020 - Springer
Next-generation sequencing has enabled patient selection for targeted drugs, some of
which have shown remarkable efficacy in cancers that have the cognate molecular …

[HTML][HTML] A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases

JY Wang, MW Roehrl, VB Roehrl, MH Roehrl - Journal of Translational …, 2022 - Elsevier
Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19
pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) …

The regulatory role of RNA metabolism regulator TDP-43 in human cancer

X Ma, Y Ying, H Xie, X Liu, X Wang, J Li - Frontiers in Oncology, 2021 - frontiersin.org
TAR-DNA-binding protein-43 (TDP-43) is a member of hnRNP family and acts as both RNA
and DNA binding regulator, mediating RNA metabolism and transcription regulation in …

Development of autoantibody signatures for common cancers

M Kobayashi, H Katayama, JF Fahrmann… - Seminars in …, 2020 - Elsevier
A humoral immune response in the form of autoantibodies to tumor antigens occurs early
during tumor development. Identification of antigens that induce an autoantibody response …